Nationwide Fund Advisors - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 146 filers reported holding NEKTAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2017$4,317,000
+105.3%
179,877
+67.2%
0.02%
+112.5%
Q2 2017$2,103,000
+8.4%
107,555
+30.1%
0.01%0.0%
Q1 2017$1,940,000
+78.5%
82,680
-6.7%
0.01%
+60.0%
Q4 2016$1,087,000
-24.5%
88,587
+5.7%
0.01%
-16.7%
Q3 2016$1,440,000
+19.6%
83,846
-0.9%
0.01%
+20.0%
Q2 2016$1,204,000
+1.2%
84,618
-0.6%
0.01%0.0%
Q1 2016$1,190,000
-18.4%
85,166
-1.6%
0.01%
-16.7%
Q4 2015$1,459,000
+57.1%
86,558
+2.1%
0.01%
+50.0%
Q3 2015$929,000
-13.1%
84,777
-0.8%
0.00%0.0%
Q2 2015$1,069,000
-15.5%
85,453
-25.7%
0.00%
-20.0%
Q1 2015$1,265,000
-30.8%
114,971
-2.6%
0.01%
-37.5%
Q4 2014$1,829,000
+29.7%
117,995
+1.0%
0.01%
+33.3%
Q3 2014$1,410,000
-5.7%
116,820
+0.1%
0.01%0.0%
Q2 2014$1,496,000
+7.2%
116,710
+1.3%
0.01%0.0%
Q1 2014$1,396,000
+14.0%
115,181
+6.7%
0.01%
+20.0%
Q4 2013$1,225,000
+7.3%
107,963
-1.2%
0.01%0.0%
Q3 2013$1,142,000
+13.1%
109,305
+25.0%
0.01%0.0%
Q2 2013$1,010,00087,4560.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders